Premium
Changes in patient backgrounds may increase the incidence of HCC after SVR in the era of IFN‐free therapy for HCV
Author(s) -
Toyoda Hidenori,
Kumada Takashi,
Tada Toshifumi
Publication year - 2016
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.28632
Subject(s) - medicine , cirrhosis , hepatocellular carcinoma , incidence (geometry) , tolerability , gastroenterology , hepatitis c virus , hepatitis c , interferon , immunology , oncology , adverse effect , virus , physics , optics
JF, et al. A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. HEPATOLOGY 1997; 26:1115-1122. 3) Jirkovsky V, Fejfar T, Safka V, Hulek P, Krajina A, Chovanec V, et al. Influence of the secondary deployment of expanded polytetrafluoroethylene-covered stent grafts on maintenance of transjugular intrahepatic portosystemic shunt patency. J Vasc Interv Radiol 2011;22:55-60. CopyrightVC 2016 by the American Association for the Study of Liver Diseases.